LifeClean International AB

As of June 30, 2026, LifeClean International AB carries a market capitalization of 37.00M, placing it among publicly traded companies globally. Its enterprise value stands at 23.67M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

LifeClean International AB's next confirmed earnings release is scheduled for February 18, 2027.

As of June 30, 2026, LifeClean International AB has 1.16B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.28, and the price-to-book ratio stands at 0.97.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 23.67M versus a market cap of 37.00M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, LifeClean International AB maintains a current ratio of 2.47, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -45.81, reflecting losses generated across the asset base. The company generates approximately 2.48M in revenue per employee across its workforce of 23.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.54 indicates how many times LifeClean International AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, LifeClean International AB recorded an income tax benefit of -196,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -28.79M and -28.59M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 12, 2026, LifeClean International AB's stock has declined approximately 90.93% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.05.

Over the twelve months ended June 30, 2026, LifeClean International AB generated 58.80M in revenue and converted that into -28.59M in net income, yielding earnings per share of -0.06. EBITDA reached -22.04M, while operating income came in at -28.02M.

As of June 30, 2026, LifeClean International AB holds 25.64M in cash and equivalents against 12.32M in total debt, resulting in a net debt position of -13.32M. Total book value stands at 38.23M, with working capital of 27.30M providing operational flexibility.

LifeClean International AB produced -25.80M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -800,000.00 in capital expenditures, free cash flow totaled -26.60M - equivalent to -0.05 per share.

Over the twelve months ended June 30, 2026, LifeClean International AB posted a gross margin of 47.21, reflecting its pricing power and cost economics. The operating margin of -47.66 and net profit margin of -48.63 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -162.71: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -148.04, meaning LifeClean International AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

LifeClean International AB's most recent stock split took place on March 31, 2025 with a 253:417 split ratio.